162 related articles for article (PubMed ID: 31527621)
1. Expression analysis and implication of Rab1A in gastrointestinal relevant tumor.
Xu M; Shao X; Kuai X; Zhang L; Zhou C; Cheng Z
Sci Rep; 2019 Sep; 9(1):13384. PubMed ID: 31527621
[TBL] [Abstract][Full Text] [Related]
2. Rab1A promotes cell proliferation and migration by upregulating Gli1 in colorectal cancer.
Peng C; Li X; Ye Z; Wu W
Sci Rep; 2021 Aug; 11(1):16243. PubMed ID: 34376787
[TBL] [Abstract][Full Text] [Related]
3. Rab1A knockdown represses proliferation and promotes apoptosis in gastric cancer cells by inhibition of mTOR/p70S6K pathway.
Li Z; Li Y; Jia Y; Ding B; Yu J
Arch Biochem Biophys; 2020 May; 685():108352. PubMed ID: 32240637
[TBL] [Abstract][Full Text] [Related]
4. Rab1A promotes proliferation and migration abilities via regulation of the HER2/AKT-independent mTOR/S6K1 pathway in colorectal cancer.
Cheng Z; Shao X; Xu M; Wang J; Kuai X; Zhang L; Wu J; Zhou C; Mao J
Oncol Rep; 2019 May; 41(5):2717-2728. PubMed ID: 30896866
[TBL] [Abstract][Full Text] [Related]
5. miR-15b-5p induces endoplasmic reticulum stress and apoptosis in human hepatocellular carcinoma, both in vitro and in vivo, by suppressing Rab1A.
Yang Y; Hou N; Wang X; Wang L; Chang S; He K; Zhao Z; Zhao X; Song T; Huang C
Oncotarget; 2015 Jun; 6(18):16227-38. PubMed ID: 26023735
[TBL] [Abstract][Full Text] [Related]
6. Aberrant amino acid signaling promotes growth and metastasis of hepatocellular carcinomas through Rab1A-dependent activation of mTORC1 by Rab1A.
Xu BH; Li XX; Yang Y; Zhang MY; Rao HL; Wang HY; Zheng XF
Oncotarget; 2015 Aug; 6(25):20813-28. PubMed ID: 26308575
[TBL] [Abstract][Full Text] [Related]
7. Clinical value and potential association of Rab1A and FoxM1 aberrant expression in colorectal cancer.
Xu M; Shao X; Li H; Zhang Z; Zhou C; Cheng Z
Sci Rep; 2020 Nov; 10(1):20160. PubMed ID: 33214609
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of Rab1A and its prognostic significance in human colorectal cancer.
Wang ZK; Cheng ZW; Chen SJ; Zhu XG; Gu YP; Yang XD; Sun L; Liu WT; Zhang YJ; Yuan JF; Tian KJ; Yao YZ; He SB
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4509-4517. PubMed ID: 30058685
[TBL] [Abstract][Full Text] [Related]
9. Rab1A is an mTORC1 activator and a colorectal oncogene.
Thomas JD; Zhang YJ; Wei YH; Cho JH; Morris LE; Wang HY; Zheng XF
Cancer Cell; 2014 Nov; 26(5):754-69. PubMed ID: 25446900
[TBL] [Abstract][Full Text] [Related]
10. Expression of Rab1A is upregulated in human lung cancer and associated with tumor size and T stage.
Wang X; Liu F; Qin X; Huang T; Huang B; Zhang Y; Jiang B
Aging (Albany NY); 2016 Nov; 8(11):2790-2798. PubMed ID: 27902464
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
Ge F; Wang C; Wang W; Liu W; Wu B
Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of RAB1A suppresses epithelial-mesenchymal transition and proliferation of triple-negative breast cancer cells.
Xu H; Qian M; Zhao B; Wu C; Maskey N; Song H; Li D; Song J; Hua K; Fang L
Oncol Rep; 2017 Mar; 37(3):1619-1626. PubMed ID: 28184936
[TBL] [Abstract][Full Text] [Related]
13. Prognosis, Significance and Positive Correlation of Rab1A and p-S6K/Gli1 Expression in Gastric Cancer.
Shao X; Cheng Z; Xu M; Mao J; Wang J; Zhou C
Anticancer Agents Med Chem; 2019; 19(11):1359-1367. PubMed ID: 31038077
[TBL] [Abstract][Full Text] [Related]
14. miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.
Zhang CZ; Cao Y; Fu J; Yun JP; Zhang MF
Mol Oncol; 2016 Dec; 10(10):1532-1541. PubMed ID: 27693040
[TBL] [Abstract][Full Text] [Related]
15. Pooled analysis of prognostic value and clinical significance of Rab1A expression in human solid tumors.
Shao X; Cheng Z; Xu M; Tan Z; Gao L; Wang J; Zhou C
Medicine (Baltimore); 2019 Dec; 98(50):e18370. PubMed ID: 31852145
[TBL] [Abstract][Full Text] [Related]
16. MiR-1202 functions as a tumor suppressor in glioma cells by targeting Rab1A.
Quan Y; Song Q; Wang J; Zhao L; Lv J; Gong S
Tumour Biol; 2017 Apr; 39(4):1010428317697565. PubMed ID: 28443461
[TBL] [Abstract][Full Text] [Related]
17. A-kinase-interacting protein 1 facilitates growth and metastasis of gastric cancer cells via Slug-induced epithelial-mesenchymal transition.
Chen D; Cao G; Liu Q
J Cell Mol Med; 2019 Jun; 23(6):4434-4442. PubMed ID: 31020809
[TBL] [Abstract][Full Text] [Related]
18. miR‑139‑3p suppresses the invasion and migration properties of breast cancer cells by targeting RAB1A.
Zhang W; Xu J; Wang K; Tang X; He J
Oncol Rep; 2019 Nov; 42(5):1699-1708. PubMed ID: 31485677
[TBL] [Abstract][Full Text] [Related]
19. Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors.
Xu L; Cai Y; Chen X; Zhu Y; Cai J
BMC Cancer; 2021 Sep; 21(1):989. PubMed ID: 34479528
[TBL] [Abstract][Full Text] [Related]
20. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
